Foundation says about 40mn children are at risk of stunted growth as climate change worsens food security
Results offer hope of progress in combating bladder tumours and some forms of breast cancer
High rates of vomiting among those who took strong doses in trials have unsettled investors
Company’s chief oncology officer says reforms risk discouraging treatments for paediatric and rare conditions
Rita Charon believes that letting patients tell their own stories is the best way to fix a broken system
Some opt for a data-led utilitarian approach; others say treat contributions like an investment portfolio
More aggressive actions and better co-ordinated responses needed to contain viruses, say public health experts
Flying blind is dangerous. Technology can build on the basics of local and national data collection
Issue hampers effort to exploit mRNA technology’s promise in tackling deadly viral outbreaks
CDC officials recount the critical role of politicians and others surrounding the story of HIV
Early warning system requires roll out of latest testing techniques, Covid levels of co-operation and greater regulatory harmonisation
UCL unveils new sensory device that will help doctors to spot disease early and advance robotic surgery
Medical breakthroughs come with spiralling price tag, leaving policymakers with tough decisions
Farmers fear for livelihoods as government struggles to stem worst outbreak of virus in decades
European Court of Auditors says closer co-operation on data and testing would help fix shortcomings exposed by Covid
Scientists’ goal is not to resurrect vanished creatures but discover whether ancient molecules can solve modern problems
Groups managing more than $13tn cite ‘economic imperative’ of finding ways to reduce superbugs’ spread
Also in this newsletter: the Netherlands refuses to donate mpox vaccines to Africa
A three-part FT series looks at how an influx of money is changing prospects for patients but creating new challenges for healthcare systems
Pandemic winners BioNTech and Moderna face hurdles as they seek to bring their groundbreaking technology to oncology
More trials urged as part of effort to slow cognitive declines with existing medicines
Wealthy world must help Africa prevent a potential regional health catastrophe
Nice’s ruling on lecanemab demonstrates the lack of readiness to roll out new treatments in the UK
The first in an FT series looking at the new energy behind the fight for cancer cures
Pharma groups are finally turning their research focus to a huge unmet need
